Note: Ingredients listed on restricted chemical lists
EC/CAS
80-08-0
Name of the chemical
4,4′-diaminodiphenyl sulphone
Concentration
< 10
EC/CAS
108-88-3
Name of the chemical
Toluene
Concentration
<= 0.625
General Information
Version
53.00
Revision date
2023-08-09
Product name
3M Scotch-Weld Structural Adhesive Film AF 191
supplier name
3M
Manufacturer Name
3M
Emergency telephone
1-800-364-3577 or (651) 737-6501 (24 hours
Icons in SDS
Company Information
company name
3M
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Reproductive Toxicity: Category 1B. Reproductive Toxicity: Lactation. Specific Target Organ Toxicity (single exposure): Category 1. Specific Target Organ Toxicity (repeated exposure): Category 1.
Hazard statements
May damage fertility or the unborn child. May cause harm to breast-fed children. Causes damage to organs: blood or blood-forming organs | liver | Causes damage to organs through prolonged or repeated exposure: blood or blood-forming organs | liver | May cause damage to organs through prolonged or repeated exposure: nervous system |
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapors/spray. Avoid contact during pregnancy/while nursing. Wear protective gloves. Do not eat, drink or smoke when using this product. Wash thoroughly after handling.
Response
IF exposed or concerned: Get medical advice/attention. Specific treatment (see Notes to Physician on this label).
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with applicable local/regional/national/international regulations. Notes to Physician: Overexposure to this product may result in methemoglobinemia. Methemoglobinemia may be clinically suspected by the presence of clinical "cyanosis" in the presence of a normal PaO2 (as obtained by arterial blood gases). Routine pulse oximetry may be inaccurate for monitoring oxygen saturation in the presence of methemoglobinemia, and should not be used to make the diagnosis of this disorder. If the patient is symptomatic or if the methemoglobin level is >20%, specific therapy with methylene blue should be considered as part of the medical management. 15% of the mixture consists of ingredients of unknown acute dermal toxicity.